Literature DB >> 15189738

Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages.

Helen E Porritt1, Lynn L Rumfelt, Sahba Tabrizifard, Thomas M Schmitt, Juan Carlos Zúñiga-Pflücker, Howard T Petrie.   

Abstract

The nature of early T lineage progenitors in the thymus or bone marrow remains controversial. Here we assess lineage capacity and proliferative potential among five distinct components of the earliest intrathymic stage (DN1, CD25(-)44(+)). All of these express one or more hemato-lymphoid lineage markers. All can produce T lineage cells, but only two of them display kinetics of differentiation, proliferative capacity, and other traits consistent with being canonical T progenitors. The latter also appeared limited to producing cells of the T or NK lineages, while B lineage potential derived mainly from the other, less typical T progenitors. In addition to precisely defining canonical early progenitors in the thymus, this work reconciles conflicting results from numerous groups by showing that multiple progenitors with a DN1 phenotype home to the thymus and make T cells, but possess different proliferative potentials and lineage capacities.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15189738     DOI: 10.1016/j.immuni.2004.05.004

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  152 in total

1.  The earliest intrathymic precursors of CD8α(+) thymic dendritic cells correspond to myeloid-type double-negative 1c cells.

Authors:  Hervé Luche; Laurence Ardouin; Pearline Teo; Peter See; Sandrine Henri; Miriam Merad; Florent Ginhoux; Bernard Malissen
Journal:  Eur J Immunol       Date:  2011-07-04       Impact factor: 5.532

Review 2.  Determining γδ versus αß T cell development.

Authors:  Maria Ciofani; Juan Carlos Zúñiga-Pflücker
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

Review 3.  Functional diversity of stem and progenitor cells with B-lymphopoietic potential.

Authors:  Michiko Ichii; Tomoyuki Shimazu; Robert S Welner; Karla P Garrett; Qingzhao Zhang; Brandt L Esplin; Paul W Kincade
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

Review 4.  Decision checkpoints in the thymus.

Authors:  Andrea C Carpenter; Rémy Bosselut
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

5.  Single-Cell RNA-Seq Mapping of Human Thymopoiesis Reveals Lineage Specification Trajectories and a Commitment Spectrum in T Cell Development.

Authors:  Justin Le; Jeong Eun Park; Vi Luan Ha; Annie Luong; Sergio Branciamore; Andrei S Rodin; Grigoriy Gogoshin; Fan Li; Yong-Hwee Eddie Loh; Virginia Camacho; Sweta B Patel; Robert S Welner; Chintan Parekh
Journal:  Immunity       Date:  2020-06-16       Impact factor: 31.745

6.  T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBFbeta dosage.

Authors:  Laleh Talebian; Zhe Li; Yalin Guo; Justin Gaudet; Maren E Speck; Daisuke Sugiyama; Prabhjot Kaur; Warren S Pear; Ivan Maillard; Nancy A Speck
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

Review 7.  The development and function of thymic B cells.

Authors:  Jason Perera; Haochu Huang
Journal:  Cell Mol Life Sci       Date:  2015-04-03       Impact factor: 9.261

8.  HEB-deficient T-cell precursors lose T-cell potential and adopt an alternative pathway of differentiation.

Authors:  Marsela Braunstein; Michele K Anderson
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

9.  Propensity of adult lymphoid progenitors to progress to DN2/3 stage thymocytes with Notch receptor ligation.

Authors:  Jiaxue Huang; Karla P Garrett; Rosana Pelayo; Juan Carlos Zúñiga-Pflücker; Howard T Petrie; Paul W Kincade
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

10.  E proteins are required to activate germline transcription of the TCR Vbeta8.2 gene.

Authors:  Jingquan Jia; Meifang Dai; Yuan Zhuang
Journal:  Eur J Immunol       Date:  2008-10       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.